8-KThe WireStrategic
Equity Issuance · Bylaw Amendment
Filed Jan 19, 2023 · 3y ago · Accession 0001193125-23-011002
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Cullinan Therapeutics, Inc.
- Ticker
- CGEM
- CIK
- 1789972
- Form type
- 8-K
- Filing date
- Jan 19, 2023
- Report date
- Jan 17, 2023
- Document
- d399356d8k.htm
- Size
- 418 KB